Pressure BioSciences, Inc. (OTCMKTS:PBIO)
We are checking in with PBIO this morning, as the company released a PR pertaining to the adoption of its Pressure Cycling Technology (PCT) in coronavirus research, which you’ll find below. We are also still awaiting news of the company’s partnership with Cannaworx, and the launch of its FDA-registered immune booster this month, as indicated by PBIO on December 4th.
Since we began tracking this stock, we have witnessed an impressive trading range as PBIO has moved from a low of 1.80 to yesterday’s new high of 2.75. That works out to an upswing of 53% inside of two weeks, and gives us plenty of reason to be interested in what comes next.
SOUTH EASTON, Mass., Dec. 17, 2020 /PRNewswire/ — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmetics, nutraceuticals, and food & beverage industries, today announced a remarkable convergence of global research teams announcing pivotal new insights into COVID-19 biology and disease processes. These data point to potential new pathways to next generation diagnostics and treatments. All teams selected PBI’s Pressure Cycling Technology (“PCT”) platform for their critical sample preparation steps, to help ensure that the greatest abundance and diversity of reproducible results would be revealed in the thousands of proteins involved in the affected biochemical pathways. (>>View Full PR via OTCMARKETS)
We also have a video presentation on the PBIO chart that we would suggest our readers take a moment to view:
PBIO Video Chart
For All Investor Inquiries on PBIO,Contact:
Gary Zwetchkenbaum, Plum Tree Consulting LLC
Phone: (516) 455-7662
The Toro Co. TTC – Recap
We included the TTC Weekly $90-95 Calls as a possible options trading idea in yesterday morning’s premarket report. With the help of a solid day for the markets as a whole, and the company reporting strong figures for both Q4 and the the 2020 Fiscal Year, we saw instant results.
Here are the total possible intraday gains that were on the table for those targets:
TTC Weekly $90-95 Calls
$90: 1.15-2.61 (+127%)
$95: .05-.15 (+200%)
Fresh Options Ideas:
JBL Weekly $43.50-45 Calls
LEN Weekly $75.50-77 Calls
ACN Weekly $255-262.50 Calls